Categories AlphaGraphs, Earnings, Health Care
Bristol-Myers Squibb (BMY) reports higher Q1 profit; revenue down 3%
Biotechnology company Bristol Myers Squibb (NYSE: BMY) said its first-quarter adjusted earnings increased modestly, despite a decline in revenues.
Net income attributable to shareholders was $2.26 billion or $1.07 per share in the March quarter, compared to $1.28 billion or $0.59 per share in the comparable period of 2022. Adjusted profit increased 5% annually to $2.05 per share.
Meanwhile, first-quarter revenues decreased 3% from last year to $11.34 billion. Domestic sales rose by 4% while international sales decreased by 16%.
Prior Performance
Most Popular
WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable retail environment. These factors have put pressure on the drugstore
Main points from Accenture’s (ACN) Q3 2024 earnings report
Shares of Accenture (NYSE: ACN) rose 6% on Thursday, following the company’s announcement of its third-quarter 2024 earnings results. Although revenue and profits missed expectations, the stock jumped after the
ACB Earnings: Aurora Cannabis reports narrower Q4 loss on higher revenues
Aurora Cannabis, Inc. (NASDAQ: ACB) on Thursday reported a net loss for the fourth quarter of 2024. The company’s revenues moved up 5% year-over-year during the quarter. The Canada-based recreational
